{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T11:15:56Z","timestamp":1777893356747,"version":"3.51.4"},"reference-count":40,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"am","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01 CA237005"],"award-info":[{"award-number":["R01 CA237005"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R25CA288263"],"award-info":[{"award-number":["R25CA288263"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["brachyjournal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brachytherapy"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.brachy.2025.03.001","type":"journal-article","created":{"date-parts":[[2025,4,6]],"date-time":"2025-04-06T02:56:47Z","timestamp":1743908207000},"page":"486-494","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Primary vaginal cancer treated with high-dose rate brachytherapy and intraprocedural magnetic resonance imaging"],"prefix":"10.1016","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4378-117X","authenticated-orcid":false,"given":"Ulysses G.","family":"Gardner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6545-7245","authenticated-orcid":false,"given":"Keara","family":"English","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2429-0690","authenticated-orcid":false,"given":"Michael","family":"Roumeliotis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6600-5638","authenticated-orcid":false,"given":"Serena","family":"Mao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Todd","family":"McNutt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4607-9570","authenticated-orcid":false,"given":"Mohammad","family":"Rezaee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junghoon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akila N.","family":"Viswanathan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.brachy.2025.03.001_bib0001","first-page":"7","article-title":"Cancer statistics, 2020","volume":"70","author":"Siegel","year":"2020","journal-title":"CA Cancer J Clin"},{"issue":"11","key":"10.1016\/j.brachy.2025.03.001_bib0002","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.3390\/v13112234","article-title":"Human papillomaviruses-associated cancers: an update of current knowledge","volume":"13","author":"Pe\u0161ut","year":"2021","journal-title":"Viruses"},{"issue":"7","key":"10.1016\/j.brachy.2025.03.001_bib0003","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1002\/eji.1830190711","article-title":"Intracellular events associated with inhibition of B cell activation by monoclonal antibodies to HLA class II antigens","volume":"19","author":"Holte","year":"1989","journal-title":"Eur J Immunol"},{"issue":"1","key":"10.1016\/j.brachy.2025.03.001_bib0004","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.ijrobp.2004.09.032","article-title":"Definitive radiation therapy for squamous cell carcinoma of the vagina","volume":"62","author":"Frank","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.brachy.2025.03.001_bib0005","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0090-8258(03)00401-3","article-title":"A comparative analysis of human papillomavirus types 16 and 18 and expression of p53 gene and ki-67 in cervical, vaginal, and vulvar carcinomas","volume":"90","author":"Koyamatsu","year":"2003","journal-title":"Gynecol Oncol"},{"issue":"5","key":"10.1016\/j.brachy.2025.03.001_bib0006","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1097\/IGC.0b013e31821bc615","article-title":"The prognostic role of human papillomavirus in patients with vaginal cancer","volume":"21","author":"Brunner","year":"2011","journal-title":"Int J Gynecol Cancer"},{"issue":"2","key":"10.1016\/j.brachy.2025.03.001_bib0007","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.ygyno.2013.02.004","article-title":"Prognostic impact of human papilloma virus (HPV) genotyping and HPV-16 subtyping in vaginal carcinoma","volume":"129","author":"Larsson","year":"2013","journal-title":"Gynecol Oncol"},{"issue":"5","key":"10.1016\/j.brachy.2025.03.001_bib0008","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1097\/AOG.0b013e31819fe844","article-title":"Factors affecting risk of mortality in women with vaginal cancer","volume":"113","author":"Shah","year":"2009","journal-title":"Obstet Gynecol"},{"issue":"5","key":"10.1016\/j.brachy.2025.03.001_bib0009","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/0360-3016(95)02394-1","article-title":"Definitive radiotherapy for carcinoma of the vagina: outcome and prognostic factors","volume":"35","author":"Chyle","year":"1996","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.brachy.2025.03.001_bib0010","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1006\/gyno.1995.1008","article-title":"A 30-year experience in the management of primary carcinoma of the vagina: analysis of prognostic factors and treatment modalities","volume":"56","author":"Stock","year":"1995","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.brachy.2025.03.001_bib0011","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.radonc.2004.12.015","article-title":"Recommendations from gynaecological (GYN) GEC-ESTRO Working Group (I): concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV","volume":"74","author":"Haie-Meder","year":"2005","journal-title":"Radiother Oncol"},{"issue":"1","key":"10.1016\/j.brachy.2025.03.001_bib0012","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1634\/theoncologist.2017-0546","article-title":"Definitive radiotherapy in invasive vaginal carcinoma: a systematic review","volume":"24","author":"Guerri","year":"2019","journal-title":"Oncologist"},{"issue":"15","key":"10.1016\/j.brachy.2025.03.001_bib0013","doi-asserted-by":"crossref","first-page":"4458","DOI":"10.3390\/jcm13154458","article-title":"New frontiers in locally advanced cervical cancer treatment","volume":"13","author":"Massobrio","year":"2024","journal-title":"J Clin Med"},{"issue":"1","key":"10.1016\/j.brachy.2025.03.001_bib0014","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1177\/03008916211056369","article-title":"Vaginal cancer treated with curative radiotherapy with or without concomitant chemotherapy: oncologic outcomes and prognostic factors","volume":"109","author":"Meixner","year":"2023","journal-title":"Tumori"},{"issue":"1","key":"10.1016\/j.brachy.2025.03.001_bib0015","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.brachy.2011.06.008","article-title":"American Brachytherapy Society consensus guidelines for interstitial brachytherapy for vaginal cancer","volume":"11","author":"Beriwal","year":"2012","journal-title":"Brachytherapy."},{"issue":"4","key":"10.1016\/j.brachy.2025.03.001_bib0016","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/S0360-3016(03)00217-7","article-title":"High-dose-rate (HDR) brachytherapy with or without external beam radiotherapy in the treatment of primary vaginal carcinoma: long-term results and side effects","volume":"56","author":"Mock","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.brachy.2025.03.001_bib0017","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.ygyno.2018.06.011","article-title":"Image-based multichannel vaginal cylinder brachytherapy for the definitive treatment of gynecologic malignancies in the vagina","volume":"150","author":"Gebhardt","year":"2018","journal-title":"Gynecolog Oncol"},{"issue":"4","key":"10.1016\/j.brachy.2025.03.001_bib0018","doi-asserted-by":"crossref","first-page":"312","DOI":"10.5114\/jcb.2015.54053","article-title":"Brachytherapy for malignancies of the vagina in the 3D era","volume":"7","author":"Glaser","year":"2015","journal-title":"J Contemp Brachyther"},{"issue":"3","key":"10.1016\/j.brachy.2025.03.001_bib0019","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.radonc.2016.05.019","article-title":"Outcomes with image-based interstitial brachytherapy for vaginal cancer","volume":"120","author":"Manuel","year":"2016","journal-title":"Radiother Oncol"},{"issue":"1","key":"10.1016\/j.brachy.2025.03.001_bib0020","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/1754-9485.12984","article-title":"Comparison of accuracy and long-term prognosis between computed tomography-based and magnetic resonance imaging-based brachytherapy for cervical cancer: a meta-analysis","volume":"64","author":"Wang","year":"2020","journal-title":"J Med Imag Rad Onc"},{"issue":"2","key":"10.1016\/j.brachy.2025.03.001_bib0021","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.ijrobp.2014.06.005","article-title":"Comparison and consensus guidelines for delineation of clinical target volume for CT- and MR-based brachytherapy in locally advanced cervical cancer","volume":"90","author":"Viswanathan","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1016\/j.brachy.2025.03.001_bib0022","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1093\/jjco\/hys010","article-title":"CT or MRI for image-based brachytherapy in cervical cancer","volume":"42","author":"Krishnatry","year":"2012","journal-title":"Japan J Clin Oncol"},{"issue":"3","key":"10.1016\/j.brachy.2025.03.001_bib0023","doi-asserted-by":"crossref","first-page":"e157","DOI":"10.1016\/S1470-2045(19)30855-1","article-title":"Definitive radiotherapy with image-guided adaptive brachytherapy for primary vaginal cancer","volume":"21","author":"Westerveld","year":"2020","journal-title":"Lancet Oncol"},{"issue":"6","key":"10.1016\/j.brachy.2025.03.001_bib0024","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.3390\/cancers13061459","article-title":"Image-guided adaptive brachytherapy (IGABT) for primary vaginal cancer: results of the International Multicenter RetroEMBRAVE cohort study","volume":"13","author":"Westerveld","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.brachy.2025.03.001_bib0025","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.brachy.2014.10.001","article-title":"Image-based multichannel vaginal cylinder brachytherapy for vaginal cancer","volume":"14","author":"Vargo","year":"2015","journal-title":"Brachytherapy"},{"issue":"1","key":"10.1016\/j.brachy.2025.03.001_bib0026","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.brachy.2022.09.002","article-title":"Outcomes of 3D MRI based HDR brachytherapy with hybrid multichannel vaginal cylinder applicator and freehand needles for treatment of vaginal disease","volume":"22","author":"Mulherkar","year":"2023","journal-title":"Brachytherapy"},{"issue":"1052","key":"10.1016\/j.brachy.2025.03.001_bib0027","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20150033","article-title":"Primary vaginal cancer: role of MRI in diagnosis, staging and treatment","volume":"88","author":"Gardner","year":"2015","journal-title":"Br J Radiol"},{"issue":"3","key":"10.1016\/j.brachy.2025.03.001_bib0028","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.radonc.2016.05.019","article-title":"Outcomes with image-based interstitial brachytherapy for vaginal cancer","volume":"120","author":"Manuel","year":"2016","journal-title":"Radiother Oncol"},{"issue":"1","key":"10.1016\/j.brachy.2025.03.001_bib0029","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.brachy.2020.08.020","article-title":"The impact of brachytherapy boost and radiotherapy treatment duration on survival in patients with vaginal cancer treated with definitive chemoradiation","volume":"20","author":"Reshko","year":"2021","journal-title":"Brachytherapy"},{"issue":"1","key":"10.1016\/j.brachy.2025.03.001_bib0030","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.brachy.2020.08.020","article-title":"The impact of brachytherapy boost and radiotherapy treatment duration on survival in patients with vaginal cancer treated with definitive chemoradiation","volume":"20","author":"Reshko","year":"2021","journal-title":"Brachytherapy"},{"issue":"3","key":"10.1016\/j.brachy.2025.03.001_bib0031","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.ijrobp.2019.10.042","article-title":"A phase II trial of stereotactic ablative radiation therapy as a boost for locally advanced cervical cancer","volume":"106","author":"Albuquerque","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.brachy.2025.03.001_bib0032","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.radonc.2019.11.005","article-title":"Recommendations from gynaecological (GYN) GEC-ESTRO working group\u2014ACROP: target concept for image guided adaptive brachytherapy in primary vaginal cancer","volume":"145","author":"Schmid","year":"2020","journal-title":"Radiother Oncol"},{"issue":"4","key":"10.1016\/j.brachy.2025.03.001_bib0033","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/j.ijrobp.2016.02.043","article-title":"Consensus recommendations for radiation therapy contouring and treatment of vulvar carcinoma","volume":"95","author":"Gaffney","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.brachy.2025.03.001_bib0034","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s13014-024-02499-2","article-title":"Inversion-recovery ultrashort-echo-time (IR-UTE) MRI-based detection of radiation dose heterogeneity in gynecologic cancer patients treated with HDR brachytherapy","volume":"19","author":"Sheikh","year":"2024","journal-title":"Radiat Oncol"},{"issue":"15","key":"10.1016\/j.brachy.2025.03.001_bib0035","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1056\/NEJM199904153401502","article-title":"Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer","volume":"340","author":"Rose","year":"1999","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.brachy.2025.03.001_bib0036","doi-asserted-by":"crossref","first-page":"e65048","DOI":"10.1371\/journal.pone.0065048","article-title":"Concurrent chemoradiation for vaginal cancer","volume":"8","author":"Miyamoto","year":"2013","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.brachy.2025.03.001_bib0037","doi-asserted-by":"crossref","first-page":"512","DOI":"10.5114\/jcb.2016.64511","article-title":"Acute and late vaginal toxicity after adjuvant high-dose-rate vaginal brachytherapy in patients with intermediate risk endometrial cancer: is local therapy with hyaluronic acid of clinical benefit?","volume":"8","author":"Laliscia","year":"2016","journal-title":"J Contemp Brachytherapy"},{"issue":"1","key":"10.1016\/j.brachy.2025.03.001_bib0038","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ijrobp.2014.01.032","article-title":"Manifestation pattern of early-late vaginal morbidity after definitive radiation (chemo)therapy and image-guided adaptive brachytherapy for locally advanced cervical cancer: an analysis from the EMBRACE study","volume":"89","author":"Kirchheiner","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.brachy.2025.03.001_bib0039","doi-asserted-by":"crossref","first-page":"E358","DOI":"10.1016\/j.ijrobp.2019.06.1690","article-title":"IMAGE-guided brachytherapy for primary vaginal cancers","volume":"105","author":"Foster","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.brachy.2025.03.001_bib0040","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.ygyno.2020.11.025","article-title":"Vaginal necrosis: a rare late toxicity after radiation therapy","volume":"160","author":"Jia","year":"2021","journal-title":"Gynecol Oncol"}],"container-title":["Brachytherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472125000406?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538472125000406?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T06:55:41Z","timestamp":1777618541000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538472125000406"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S1538472125000406"],"URL":"https:\/\/doi.org\/10.1016\/j.brachy.2025.03.001","relation":{},"ISSN":["1538-4721"],"issn-type":[{"value":"1538-4721","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Primary vaginal cancer treated with high-dose rate brachytherapy and intraprocedural magnetic resonance imaging","name":"articletitle","label":"Article Title"},{"value":"Brachytherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brachy.2025.03.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Brachytherapy Society. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}